ACUTAAS Share Price Performance
₹0
-1413.60 (-100.00%)
Price ₹0
Fair Value₹2,552.00
Share Pricen/a
Analysis Article • Aug 21
Acutaas Chemicals Limited Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 22 Fair Values set on narratives written by author
ACUTAAS Community Narratives
AN
Fair Value
·Fair Value ₹2.55k 27.7% overvalued intrinsic discount
ACUTAAS: Profit Margin and Earnings Outlook Will Support Medium-Term Opportunity
0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
AN
Fair Value
·Fair Value ₹4k 18.6% undervalued intrinsic discount
Battery And Semiconductor Chemicals Are Expected To Drive Powerful Future Upside
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value
·Fair Value ₹1.42k 128.9% overvalued intrinsic discount
Battery And Semiconductor Expansion Will Expose Capacity Risks And Pressure Long Term Margins
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Battery And Semiconductor Expansion Will Expose Capacity Risks And Pressure Long Term Margins
Acutaas Chemicals is ramping up into battery and chip-making chemicals, but much of the new battery capacity leans on one big export deal—so a change in demand or pricing could leave expensive new plants sitting idle. Add in reliance on a joint-venture partner and the chance that new product lines take longer to matter, and the path to steady profits may be bumpier than it looks.Read more
AN
₹1.42k
128.9% overvalued intrinsic discount
Fair Value
Revenue
20.3% p.a.
Profit Margin
31.02%
Future PE
20.75x
Price in 2029
₹2k
Battery And Semiconductor Chemicals Are Expected To Drive Powerful Future Upside
Acutaas Chemicals is betting on fast-growing markets like battery and chipmaking chemicals, while scaling its drug-development services to bring in steadier, higher-quality business. The upside depends on new plants and customer wins arriving on time—because delays, shifting demand, or tougher competition could quickly cool the story.Read more
AN
₹4k
18.6% undervalued intrinsic discount
Fair Value
Revenue
37.41% p.a.
Profit Margin
26.1%
Future PE
46.64x
Price in 2029
₹5.64k
ACUTAAS: Profit Margin and Earnings Outlook Will Support Medium-Term Opportunity
Ami Organics is pushing into higher-value drug-making services and new end markets like semiconductors, aiming to grow faster while keeping profits healthy. But delays at new facilities and shaky demand could derail that growth and leave today’s expectations looking too optimistic.Read more
AN
₹2.55k
27.7% overvalued intrinsic discount
Fair Value
Revenue
28.46% p.a.
Profit Margin
26.06%
Future PE
39.8x
Price in 2029
₹3.59k
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
ACUTAAS: Elevated Margin Assumptions Will Likely Expose Downside At Upcoming Board Review
Fair Value: ₹1.42k 128.9% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
ACUTAAS: Higher Profitability Outlook And Q1 Results Will Support A Measured Future
Fair Value: ₹4k 18.6% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
ACUTAAS: Rich Future P E And Final Dividend Will Pressure Returns
Fair Value: ₹2.55k 27.7% overvalued intrinsic discount
9 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Acutaas Chemicals Limited Key Details
About ACUTAAS
- Founded
- 2004
- Employees
- 879
- CEO
- WebsiteView website
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson’s, antidepressant, and anticoagulant applications. It also provides specialty chemicals for use in battery chemicals, personal care, agrochemicals, coatings, electronics, and industrial processes; photoresist chemicals to semiconductor applications; electrolyte additives for lithium battery cells; and parabens, methyl salicylate, and other commodity chemicals for cosmetics, agrochemicals, and fine chemicals. The company was formerly known as Ami Organics Limited and changed its name to Acutaas Chemicals Limited in May 2025. Acutaas Chemicals Limited was founded in 2004 and is based in Surat, India.
Recent ACUTAAS News & Updates
Narrative Update • Aug 19
